dementia
Well Pharmacy and Alzheimer’s Society launch dementia partnership
June 2, 2026Research and Development dementia
Well Pharmacy has announced a partnership with Alzheimer’s Society aimed at improving support for people living with dementia and their …
Vesper Bio reports positive topline results for dementia candidate
November 7, 2025Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia
Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …
Lilly’s drug for early Alzheimer’s shows promising results
August 6, 2025Medical Communications, Research and Development Alzheimer's, Eli Lilly, Neurology, dementia
Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase 3 study, showing that Kisunla …
Mental health medicine use in England reaches record high, NHSBSA report reveals
July 29, 2025Manufacturing and Production, Medical Communications, Research and Development ADHD, COVID-19, NHS Business Services Authority, Psychiatry, antidepressants, antipsychotics, anxiolytics, barbiturate, dementia, hypnotics, mental health
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions in England have reached their …
Eisai and EcoNaviSta enter dementia collaboration
July 25, 2024Business Services EcoNaviSta, Eisai, Neurology, collaboration, dementia
Eisai and EcoNaviSta have announced that they have entered into a business alliance agreement, initiating their collaboration intended to build …
Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study
May 9, 2024Research and Development Alzheimer's disease, Neurocrine Biosciences, Neurology, Nxera Pharma, Parkinson's disease, clinical trials, dementia, schizophrenia
Nxera Pharma’s neuroscience-focused biopharmaceutical partner  Neurocrine Biosciences has announced it has successfully started its phase 1, first-in-human trial of investigational …
Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug
May 11, 2023Medical Communications FDA, Lundbeck, Neurology, Otsuka Pharmaceuticals, alzheimer's disease, dementia
Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US Food and Drug Administration (FDA) …
New model can help predict cognitive decline in patients with Alzheimer’s
August 5, 2019Sales and Marketing Alzheimer's pharma, cognitive decline, computing, dementia, pharma
Scientists at MIT have developed a new model which can predict whether patients at risk for Alzheimer’s disease will experience …
Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse
July 12, 2019Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research
Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …
Pfizer supressed research suggesting arthritis drug Enbrel reduced risk of Alzheimer’s by 64%
June 6, 2019Research and Development Alzheimer's, Drug therapy, Pfizer, dementia, pharma
Pfizer supressed data suggesting that their drug Enbrel reduced the risk of patients developing Alzheimer’s disease by 64%. In 2015, …
Top Ten most popular articles on Pharmafile.com this week!
May 3, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma
This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
Scientists identify new form of dementia
May 1, 2019Research and Development AD, Alzheimer's, dementia, late, neuroscience
A team of scientists from Britain and the United States have described a new form of dementia, according to a …
Heart drugs show promise in stroke and dementia
April 25, 2019Research and Development angina, cilostazol, dementia, heart drugs, isosorbide mononitrate, stroke
Drugs for heart disease and angina have shown promise as preventative treatments for stroke and dementia, according to scientists from …
Imperial College London researchers developing tech to monitor dementia patients at home
April 17, 2019Research and Development dementia, imperial college london, pharma
Researchers at Imperial College London are hard at work developing technology to aid the lives of dementia patients in their …
Google accused of profiting from misleading dementia supplement ads
March 26, 2019Manufacturing and Production Alzheimer's, dementia, google, pseudomedicine, search engines, tech
Google has been accused of profiting from false hope after running adverts for unproven dementia treatments which can cost as …
Latest content
FibroFind appoints Lee Borthwick as CEO
